Chemoinformaics analysis of Erythroxydiol Z
Molecular Weight | 1211.4 | nRot | 18 |
Heavy Atom Molecular Weight | 1112.61 | nRig | 7 |
Exact Molecular Weight | 1210.63 | nRing | 9 |
Solubility: LogS | -0.179 | nHRing | 5 |
Solubility: LogP | -1.957 | No. of Aliphatic Rings | 9 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 182 | No. of Aliphatic Hetero Cycles | 5 |
No. of Heavy Atom | 84 | No. of Aromatic Carbocycles | 0 |
nHetero | 26 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 98 | No. of Saturated Hetero Cycles | 5 |
No. of Carbon atom | 58 | No. of Saturated Rings | 9 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 26 | No. of Arom Bond | 0 |
nHA | 26 | APOL | 183.058 |
nHD | 16 | BPOL | 115.674 |
QED | 0.361 |
Synth | 4.192 |
Natural Product Likeliness | 2.014 |
NR-PPAR-gamma | 0.007 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.124 |
HIA | 0.635 |
CACO-2 | -5.5 |
MDCK | 0.000443328 |
BBB | 0.454 |
PPB | 0.147514 |
VDSS | 0.434 |
FU | 0.786535 |
CYP1A2-inh | 0.015 |
CYP1A2-sub | 0.06 |
CYP2c19-inh | 0.017 |
CYP2c19-sub | 0.32 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.141 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.141 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.023 |
CL | 2.013 |
T12 | 0.725 |
hERG | 0.022 |
Ames | 0.359 |
ROA | 0.616 |
SkinSen | 0.05 |
Carcinogencity | 0.352 |
EI | 0.042 |
Respiratory | 0.034 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.869236 |